NCT06307431 · Interventional trial
A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).
Overall registry status Active not recruiting
Phase 2
Conditions Renal Cell Carcinoma
Delaware Valley sites
- Abramson Cancer Center ( Site 0107) · Philadelphia, PA · Philadelphia County
- Fox Chase Cancer Center ( Site 0111) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory